Upgrade to SI Premium - Free Trial

Medline Inc (MDLN) PT Lowered to $45 at Wells Fargo

May 11, 2026 7:56 AM
Wells Fargo analyst Stephen Baxter lowered the price target on Medline Inc (NASDAQ: MDLN) to $45.00 (from $47.00) while maintaining a Equal Weight rating.

Categories

Analyst PT Change